Metastatic Disease after Neoadjuvant Intensive Androgen Signaling Inhibition

This project focuses on the analysis of histopathological structures to identify men at high risk of metastatic disease following neoadjuvant intensive androgen signaling inhibition.

The major goal of this subaward is to employ existing pipelines to perform segmentation of histopathological structures on both biopsy and radical prostatectomy specimens. This includes the development and application of algorithms specifically designed to segment stroma from epithelium within these tissue samples. This detailed histopathological analysis is crucial for understanding disease progression and risk stratification.

Contact PI: Corey Arnold

Funding Source: Prostate Cancer Foundation